Results 181 to 190 of about 173,810 (326)
Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo +9 more
wiley +1 more source
Reaction of 1-Nitro-2, 2'-bismethylthio Ethylene. I. Reaction with Activemethylene Compounds
Goro Kobayashi +4 more
openalex +2 more sources
Competing [2 + 3] and [4 + 3] cycloadditions of C,N-diphenylnitrone with 1,3-dienes. Evidence for thermally nonequilibrated intermediates [PDF]
Baran, Janusz, Mayr, Herbert
core +1 more source
Hyperpolarization by parahydrogen‐induced polarization enhances the sensitivity of nuclear magnetic resonance spectroscopy of amino acids, peptides, mini‐proteins, and biopolymers using nonnatural amino acids with unsaturated side chains up to three orders of magnitude.
Gerd Buntkowsky
wiley +1 more source
WO<sub>3</sub> as an Electron Exchange Matrix: A Novel and Efficient Treatment Method for Nitro Compounds. [PDF]
Carmel L +6 more
europepmc +1 more source
Characterization of Room-Temperature Ionic Liquids to Study the Electrochemical Activity of Nitro Compounds. [PDF]
Banga I, Paul A, Muthukumar S, Prasad S.
europepmc +1 more source
Emission of Molecular Complexes of Nitro-compounds [PDF]
R. Foster, D. Ll. Hammick
openalex +1 more source
The cis‐2,3‐bis(trifluoromethyl)cyclopropyl chemotype is introduced. The steric demand of this motif is intermediate between that of the heptafluoroisopropyl and prefluorotertbutyl groups; yet, it induces significantly less lipophilicity than these due to its facial polarity.
Daniel Gaviña +5 more
wiley +1 more source
Reduction of chlorinated aliphatic and nitro aromatic compounds at the Fe0-oxide-water interface
Michelle M. Scherer
openalex +1 more source
Cathepsin B‐sensitive peptide–adjuvant conjugates are designed, synthesized, and evaluated to deliver an antigenic peptid and an adjuvant targeting Toll‐like receptors 7 and 8 (TLR7/8) to antigen presenting cells. The adjuvant is released by cathepsin B resulting in antigen presentation and TLR mediated T cell activation.
Marjolein M. E. Isendoorn +6 more
wiley +1 more source

